ADVANCE Proof-of-Concept study (POC):Testing a system for near real-time monitoring of vaccination coverage, benefits and risks in Europe with acellular pertussis vaccines as test case (ADVANCE POC: monitoring) First published 02/12/2018 Last updated 11/12/2018 EU PAS number:EUPAS26809 Study Ongoing